IASLC Lung Cancer News (ILCN), April 2024
ILCN | English
Image For Activity Cover
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered
In this Issue:
  • FLAURA 2 Post-progression Outcomes Demonstrate Consistent Benefit, Favor Combination Arm
  • Antibody Drug Conjugates: Diamonds in the Rough?
  • The Promise of Artificial Intelligence-Aided Pathology in Thoracic Oncology
  • US Food and Drug Administration Accepts New Drug Application for Ensartinib
  • IASLC Launches Global Member Survey on Diversity, Equity, and Inclusion
IASLC Lung Cancer News (ILCN) is the offical news source of the only global association dedicated to the multidisciplinary study of lung cancer, published bimonthly by the International Association for the Study of Lung Cancer (IASLC). 

Click here to link to Submission Guidelines.
Powered By